share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股sec公告 ·  04/18 08:21
Moomoo AI 已提取核心信息
On April 12, 2024, SeaStar Medical Holding Corporation, a company listed on NASDAQ under the trading symbol ICU, announced amendments to its corporate bylaws. The Board of Directors approved the Second Amended and Restated Bylaws, which included significant changes such as the reduction of the quorum threshold for stockholder meetings from a majority to at least 33 1/3% of the common stock issued and outstanding. Additionally, the amendments removed the definition and provisions related to 'Acting in Concert' from the bylaws, affecting how a Proposing Stockholder is identified. These changes are detailed in Exhibit 3.1 attached to the Form 8-K filed with the SEC. The company, identified as an emerging growth company, has made these amendments to streamline its governance processes. The full text of the amended bylaws is incorporated by reference into the report and is available for review.
On April 12, 2024, SeaStar Medical Holding Corporation, a company listed on NASDAQ under the trading symbol ICU, announced amendments to its corporate bylaws. The Board of Directors approved the Second Amended and Restated Bylaws, which included significant changes such as the reduction of the quorum threshold for stockholder meetings from a majority to at least 33 1/3% of the common stock issued and outstanding. Additionally, the amendments removed the definition and provisions related to 'Acting in Concert' from the bylaws, affecting how a Proposing Stockholder is identified. These changes are detailed in Exhibit 3.1 attached to the Form 8-K filed with the SEC. The company, identified as an emerging growth company, has made these amendments to streamline its governance processes. The full text of the amended bylaws is incorporated by reference into the report and is available for review.
2024年4月12日，在纳斯达克上市的交易代码为ICU的公司海星医疗控股公司宣布了其公司章程的修订。董事会批准了第二修正和重述的章程，其中包括重大变更，例如将股东会议的法定人数门槛从多数降低到已发行和流通普通股的至少 33 1/ 3%。此外，修正案从章程中删除了与 “一致行动” 相关的定义和条款，影响了提名股东的识别方式。这些变更详见向美国证券交易委员会提交的8-K表格所附的附录3.1。该公司被认定为新兴成长型公司，已进行了这些修正以简化其治理流程。经修订的章程的全文以引用方式纳入报告，可供审查。
2024年4月12日，在纳斯达克上市的交易代码为ICU的公司海星医疗控股公司宣布了其公司章程的修订。董事会批准了第二修正和重述的章程，其中包括重大变更，例如将股东会议的法定人数门槛从多数降低到已发行和流通普通股的至少 33 1/ 3%。此外，修正案从章程中删除了与 “一致行动” 相关的定义和条款，影响了提名股东的识别方式。这些变更详见向美国证券交易委员会提交的8-K表格所附的附录3.1。该公司被认定为新兴成长型公司，已进行了这些修正以简化其治理流程。经修订的章程的全文以引用方式纳入报告，可供审查。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息